180 related articles for article (PubMed ID: 14692693)
1. Phosphodiesterases in the vascular system.
Matsumoto T; Kobayashi T; Kamata K
J Smooth Muscle Res; 2003 Aug; 39(4):67-86. PubMed ID: 14692693
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.
Beavo JA
Physiol Rev; 1995 Oct; 75(4):725-48. PubMed ID: 7480160
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
Polson JB; Strada SJ
Annu Rev Pharmacol Toxicol; 1996; 36():403-27. PubMed ID: 8725396
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
7. Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.
Miller CL; Yan C
J Cardiovasc Transl Res; 2010 Oct; 3(5):507-15. PubMed ID: 20632220
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.
Keravis T; Lugnier C
Br J Pharmacol; 2012 Mar; 165(5):1288-305. PubMed ID: 22014080
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterases as therapeutic targets for respiratory diseases.
Zuo H; Cattani-Cavalieri I; Musheshe N; Nikolaev VO; Schmidt M
Pharmacol Ther; 2019 May; 197():225-242. PubMed ID: 30759374
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS.
Andersson KE; Uckert S; Stief C; Hedlund P
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):928-33. PubMed ID: 17806124
[TBL] [Abstract][Full Text] [Related]
11. Overview of PDEs and their regulation.
Omori K; Kotera J
Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
[TBL] [Abstract][Full Text] [Related]
12. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.
Bender AT; Beavo JA
Pharmacol Rev; 2006 Sep; 58(3):488-520. PubMed ID: 16968949
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.
Preedy MEJ
Cardiovasc Drugs Ther; 2020 Jun; 34(3):401-417. PubMed ID: 32172427
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of phosphodiesterase as cancer therapeutics.
Peng T; Gong J; Jin Y; Zhou Y; Tong R; Wei X; Bai L; Shi J
Eur J Med Chem; 2018 Apr; 150():742-756. PubMed ID: 29574203
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase in heart and vessels: from physiology to diseases.
Fu Q; Wang Y; Yan C; Xiang YK
Physiol Rev; 2024 Apr; 104(2):765-834. PubMed ID: 37971403
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
Xu Y; Zhang HT; O'Donnell JM
Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.
Brescia M; Zaccolo M
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706091
[TBL] [Abstract][Full Text] [Related]
18. PDE1 isozymes, key regulators of pathological vascular remodeling.
Chan S; Yan C
Curr Opin Pharmacol; 2011 Dec; 11(6):720-4. PubMed ID: 21962439
[TBL] [Abstract][Full Text] [Related]
19. The role of phosphodiesterases in schizophrenia : therapeutic implications.
Siuciak JA
CNS Drugs; 2008; 22(12):983-93. PubMed ID: 18998737
[TBL] [Abstract][Full Text] [Related]
20. [Phosphodiesterase regulation of cardiovascular functions].
Li L; He Q; Gao YS
Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):100-6. PubMed ID: 21416994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
